(Q45868043)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17498074%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

title

A systematic approach to controlling problem bleeds in patients with severe congenital haemophilia A and high-titre inhibitors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17498074%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

0 references

0 references

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17498074%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Roseline d'Oiron

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17498074%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

5

Ewenstein B

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17498074%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

6

Gomperts E

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17498074%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

author name string

Teitel J

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17498074%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Berntorp E

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17498074%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Collins P

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17498074%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Goudemand J

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17498074%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Gringeri A

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17498074%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Key N

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17498074%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Leissinger C

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17498074%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Monahan P

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17498074%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

publication date

1 May 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17498074%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17498074%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17498074%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17498074%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

256-263

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17498074%20AND%20SRC:MED&resulttype=core&format=json

Inhibitors: resolving diagnostic and therapeutic dilemmas

30 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01449.X

Prevention of bleeds in hemophilia patients with inhibitors: emerging data and clinical direction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01449.X

Literature review of surgery management in inhibitor patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01449.X

Immunoadsorption for coagulation factor inhibitors: a retrospective critical appraisal of 10 consecutive cases from a single institution

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01449.X

Control of bleeding in patients with haemophilia A with inhibitors: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01449.X

Thromboembolic adverse events after use of recombinant human coagulation factor VIIa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01449.X

Therapy for haemophilia: recent advances and goals for the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01449.X

Safety of factor VIII inhibitor bypass activity (FEIBA): 10-year compilation of thrombotic adverse events

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01449.X

Therapeutic decision-making in inhibitor patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01449.X

The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01449.X

The evidence behind inhibitor treatment with recombinant factor VIIa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01449.X

Pharmacokinetics of activated recombinant coagulation factor VII (NovoSeven) in children vs. adults with haemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01449.X

Consensus perspectives on prophylactic therapy for haemophilia: summary statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01449.X

Tolerance induction using the Malmö treatment model 1982-1995.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01449.X

Haemophilia treatment protocols around the world: towards a consensus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01449.X

Use of prothrombin complex concentrates and activated prothrombin complex concentrates as prophylactic therapy in haemophilia patients with inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01449.X

A new approach to treatment of bleeding episodes in young hemophilia patients: a single bolus megadose of recombinant activated factor VII (NovoSeven).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01449.X

Dose effect and efficacy of rFVIIa in the treatment of haemophilia patients with inhibitors: analysis from the Hemophilia and Thrombosis Research Society Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01449.X

A prospective randomized trial of high and standard dosages of recombinant factor VIIa for treatment of hemarthroses in hemophiliacs with inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01449.X

Guidelines on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01449.X

The diagnosis and management of factor VIII and IX inhibitors: a guideline from the UK Haemophilia Centre Doctors' Organization (UKHCDO).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01449.X

Intestinal surgery with activated recombinant factor VII prophylaxis in patients with haemophilia A and high responding inhibitors: a report of five cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01449.X

Role of epsilon amino caproic acid in the management of haemophilic patients with inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01449.X

Safety, efficacy and lessons from continuous infusion with rFVIIa. rFVIIa-CI Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01449.X

Manipulation of prothrombin concentration improves response to high-dose factor VIIa in a cell-based model of haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01449.X

Sequential therapy with activated prothrombin complex concentrate and recombinant factor VIIa in patients with severe haemophilia and inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01449.X

Factors affecting choice of hemostatic agent for the hemophilia patient with an inhibitor antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01449.X

Impact of choice of treatment for bleeding episodes on inhibitor outcome in patients with mild/moderate hemophilia a and inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01449.X

Safety profile of recombinant factor VIIa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01449.X

Therapeutic choices in the current millennium: hemophilia workshop highlights

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01449.X

Possible linkage of amprenavir with intracranial bleeding in an HIV-infected hemophiliac

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01449.X

Increased bleeding associated with protease inhibitor therapy in HIV-positive patients with bleeding disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01449.X

The economic impact of factor VIII inhibitors in patients with haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01449.X

The impact of inhibitors on the cost of clotting factor replacement therapy in Haemophilia A in Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01449.X

Views on methods for monitoring recombinant factor VIIa in inhibitor patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01449.X

10.1111/J.1365-2516.2007.01449.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17498074%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference